LP LIPTIS PHARMACEUTICALS Trademark

Trademark Overview

On Thursday, October 25, 2012, a trademark application was filed for LP LIPTIS PHARMACEUTICALS with the United States Patent and Trademark Office. The USPTO has given the LP LIPTIS PHARMACEUTICALS trademark a serial number of 85763084. The federal status of this trademark filing is REGISTERED AND RENEWED as of Friday, February 2, 2024. This trademark is owned by LIPTIS PHARMACEUTICALS USA, INC.. The LP LIPTIS PHARMACEUTICALS trademark is filed in the Pharmaceutical Products category with the following description:

A full line of pharmaceutical preparations for the treatment of osteoarthritis, sexual dysfunction, pain and inflammation, type 2 diabetes, hyperlipidemia, hypertension, enzyme deficiency, depression, GI hyperacidity, hepatic disease, gastrointestinal disease, and elevated uric acid; pharmaceutical preparations, namely, proton-pump inhibitors; antibiotic ointments for treatment of cuts and abrasions; muscle relaxants; surgical antiseptic foam; dietary and nutritional supplements for humans
lp liptis pharmaceuticals

General Information

Serial Number85763084
Word MarkLP LIPTIS PHARMACEUTICALS
Filing DateThursday, October 25, 2012
Status800 - REGISTERED AND RENEWED
Status DateFriday, February 2, 2024
Registration Number4379034
Registration DateTuesday, August 6, 2013
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, May 21, 2013

Trademark Statements

Description of MarkThe mark consists of the wording "LIPTIS Pharmaceuticals" where the word "LIPTIS" appears in blue capital letters above the word "Pharmaceuticals" in red initial capital lettering with a blue horizontal line between the two words. To the left of the wording is a blue circle containing the stylized, capital letters "LP" where the "L" is blue and the "P" is red. The white is not claimed as a feature of the mark and represents background or transparent areas.
Goods and ServicesA full line of pharmaceutical preparations for the treatment of osteoarthritis, sexual dysfunction, pain and inflammation, type 2 diabetes, hyperlipidemia, hypertension, enzyme deficiency, depression, GI hyperacidity, hepatic disease, gastrointestinal disease, and elevated uric acid; pharmaceutical preparations, namely, proton-pump inhibitors; antibiotic ointments for treatment of cuts and abrasions; muscle relaxants; surgical antiseptic foam; dietary and nutritional supplements for humans
Indication of Colors claimedThe color(s) blue and red is/are claimed as a feature of the mark.
Disclaimer with Predetermined Text"PHARMACEUTICALS"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, October 31, 2012
Primary Code005
First Use Anywhere DateMonday, March 15, 2004
First Use In Commerce DateMonday, March 15, 2004

Trademark Owner History

Party NameLIPTIS PHARMACEUTICALS USA, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSpring Valley, NY 10977
Party NameLIPTIS PHARMACEUTICALS USA, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSpring Valley, NY 10977
Party NameLIPTIS PHARMACEUTICALS USA, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBronx, NY 10472

Trademark Events

Event DateEvent Description
Friday, February 2, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Friday, February 2, 2024REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Friday, February 2, 2024REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Friday, February 2, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, August 7, 2023TEAS SECTION 8 & 9 RECEIVED
Saturday, August 6, 2022COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Saturday, March 14, 2020NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Saturday, March 14, 2020REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, March 5, 2020TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Saturday, September 14, 2019POST REGISTRATION ACTION MAILED - SEC. 8 & 15
Friday, September 13, 2019CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, August 5, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, August 5, 2019TEAS SECTION 8 & 15 RECEIVED
Monday, August 6, 2018COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, October 21, 2014TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, August 6, 2013REGISTERED-PRINCIPAL REGISTER
Thursday, July 25, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, July 25, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, May 21, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 21, 2013PUBLISHED FOR OPPOSITION
Wednesday, May 1, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 16, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, April 15, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, April 15, 2013EXAMINER'S AMENDMENT ENTERED
Monday, April 15, 2013NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, April 15, 2013EXAMINERS AMENDMENT E-MAILED
Monday, April 15, 2013EXAMINERS AMENDMENT -WRITTEN
Friday, April 12, 2013PREVIOUS ALLOWANCE COUNT WITHDRAWN
Sunday, March 31, 2013WITHDRAWN FROM PUB - OG REVIEW QUERY
Friday, March 15, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, March 7, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, March 7, 2013PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Monday, March 4, 2013PAPER RECEIVED
Thursday, February 28, 2013NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, February 28, 2013FINAL REFUSAL E-MAILED
Thursday, February 28, 2013FINAL REFUSAL WRITTEN
Tuesday, February 5, 2013AMENDMENT FROM APPLICANT ENTERED
Tuesday, February 5, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 31, 2013ASSIGNED TO LIE
Tuesday, January 29, 2013PAPER RECEIVED
Wednesday, January 23, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, January 23, 2013NON-FINAL ACTION E-MAILED
Wednesday, January 23, 2013NON-FINAL ACTION WRITTEN
Wednesday, January 16, 2013ASSIGNED TO EXAMINER
Thursday, November 1, 2012NOTICE OF DESIGN SEARCH CODE MAILED
Wednesday, October 31, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, October 29, 2012NEW APPLICATION ENTERED

Related Keywords

pharmaceuticals liptis disease treatment preparations pharmaceutical antibiotic cuts ointments inhibitors proton namely